Before 2000, many drugs that formed a covalent bond with targets did so non-selectively, which often led to undesired side effects when compared to non-covalent drugs. This led to the belief that covalent inhibitors were not ideal drug candidates, resulting in limited development by the pharmaceutical industry. However, covalent drugs have experienced a remarkable resurgence in the last few years as evidenced by the growing number of approvals by the USFDA, including the 2021 approval of Sotorasib to treat lung cancer, which was recently featured on ACS Webinars.
Databases in CAS STNext® include a wealth of citations, including both patent and non-patent literature. This information can be a steppingstone for your searches and analyses by supporting a comprehensive prior art search, finding key patents, identifying licensing opportunities, and more.
CAS STNext® contains a broad range of citation information for both patent and non- patent literature. This session will provide an overview of this type of data and tips for searching in the Derwent World Patents Index, CAplus, and other relevant databases on CAS STNext, including search examples.
CAS STNext offers powerful alerting features that help you stay up-to-date with the latest developments in your areas of interest, monitor competitor patenting activities, watch for potential infringements, and more.
In today’s accelerated pace of innovation, it is essential for organizations to leverage comprehensive IP insights to inform R&D, fuel strategic decisions, and protect their investments.
In this webinar, CAS experts will walk you through the process of obtaining your nomenclature and CAS Registry Numbers® for your WHO/INN dossiers. We will outline the information you need for your request, review a typical timeline, and provide tips on how to work with CAS to make the process run smoothly.
Looking for a comprehensive collection of global databases, scientist-curated content, and patent information? CAS STNext® is an advanced precision search and analysis tool that can power your IP searches and fuel innovation.
